MOLN Stock Summary and Trading Ideas (Molecular Partners Ag - American Depositary Shares | NASDAQ:MOLN)

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company is currently focusing on oncology through their robust pipeline of clinical and preclinical programs, with particular attention to MP0712, the key Radio-DARPin candidate targeting DLL3 now in a Phase 1/2a trial in the United States.

Molecular Partners Ag - American Depositary Shares trades on the NASDAQ stock market under the symbol MOLN.

As of April 10, 2026, MOLN stock price was flat at $4.33 with 230 million shares trading.

MOLN has a market cap of $162.01 million. This is considered a Micro Cap stock.

In the last 3 years, MOLN traded as high as $12.70 and as low as $3.32.

MOLN has underperformed the market in the last year with a price return of +16.5% while the SPY ETF gained +25.2%. However, in the short term, MOLN had mixed performance relative to the market. It has outperformed in the last 3 months, returning +5.7% vs -1.8% return in SPY. But in the last 2 weeks, MOLN shares have been beat by the market, returning +0.8% compared to an SPY return of +5.3%.

MOLN support price is $4.05 and resistance is $4.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MOLN shares will trade within this expected range on the day.